IL1B and hyperuricemia: Subsequently, it promoted the expressions of inflammation factors IL-1β and TNF-α, causing immune dysfunction and leaky gut syndrome, followed by exaggerated immune response and intestinal barrier dysfunction, which triggered hyperuricemia progression [34,38].